Rheumatoid and osteoarthritis: Preclinical applications of in vivo MR

In Vivo MR Techniques in Drug Discovery and Development

Volumn , Issue , 2006, Pages 437-463

  Laurent, Didier ^a   Beckmann, Nicolau ^b  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 50149085896     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (96)

1. Brand, D. D., Kang, A. H., and Rosloniec, E. F., Immunopathogenesis of collagen arthritis, Springer Semin. Immunopathol., 25, 3, 2003.
2. Moore, A. R., Collagen-induced arthritis, Methods Mol. Biol., 225, 175, 2003.
3. Williams, R. O., Collagen-induced arthritis as a model for rheumatoid arthritis, Methods Mol. Med., 98, 207, 2004.
4. Keystone, E. C., The utility of tumour necrosis factor blockade in orphan diseases, Ann. Rheum. Dis., 63 (Suppl. 2), ii79, 2004.
5. Cooke, T., Antigen-induced arthritis, polyarthritis, and teno-synovitis, In CRC Handbook of Animal Models for the Rheumatoid Diseases, Greenwald, R. and Diamond, H., Eds., CRC Press, Boca Raton, pp. 53-81, 1988.
6. Moskowitz, R. W. et al., Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit, Arthritis Rheum., 16, 397, 1973.
7. van den Berg, W. B., Lessons from animal models of osteoarthritis, Curr. Opin. Rheumatol., 13, 452, 2001.
8. Laurent, D. et al., Severity of Cartilage Degeneration in the Goat Knee After Meniscal Transection/Cartilage Groove Surgery as Measured by MT and Gd(DTPA)-MRI, ISMRM, 11th Scientific Meeting and Exhibition, Toronoto, Canada, May 10-16, 2003.
9. Farkas, T., Bihari-Varga, M., and Biro, T., Thermoanalytical and histological study of intra-articular papain-induced degradation and repair of rabbit cartilage. I. Immature animals, Ann. Rheum. Dis., 33, 385, 1974.
10. Laurent, D. et al., Quantitative and qualitative assessment of articular cartilage in the goat knee with magnetization transfer imaging, Magn. Reson. Imaging, 19, 1279, 2001.
11. Laurent, D. et al., In vivo assessment of macromolecular content in articular cartilage of the goat knee, Magn. Reson. Med., 49, 1037, 2003.
12. Laurent, D. et al., In vivo qualitative assessments of articular cartilage in the rabbit knee with highresolution MRI at 3 T, Magn. Reson. Med., 50, 541, 2003.
13. Kikuchi, T., Sakuta, T., and Yamaguchi, T., Intra-articular injection of collagenase induces experimental osteoarthritis in mature rabbits, Osteoarthritis Cartilage, 6, 177, 1998.
14. Guzman, R. E. et al., Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis, Toxicol. Pathol., 31, 619, 2003.
15. Sonderstrup, G., Development of humanized mice as a model of inflammatory arthritis, Springer Semin. Immunopathol., 25, 35, 2003.
16. Helminen, H. J. et al., Transgenic mouse models for studying the role of cartilage macromolecules in osteoarthritis, Rheumatology (Oxford), 41, 848, 2002.
17. Weissleder, R. and Mahmood, U., Molecular imaging, Radiology, 219, 316, 2001.
18. Faris, F. et al., Non-invasive in vivo near-infrared optical measurement of the penetration depth in the neonatal head, Clin. Phys. Physiol. Meas., 12, 353, 1991.
19. Lai, W. F. et al., Early diagnosis of osteoarthritis using cathepsin B sensitive near-infrared fluorescent probes, Osteoarthritis Cartilage, 12, 239, 2004.
20. Hansch, A. et al., In vivo imaging of experimental arthritis with near-infrared fluorescence, Arthritis Rheum., 50, 961, 2004.
21. Wunder, A. et al., In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response, Arthritis Rheum., 50, 2459, 2004.
22. Guglielmi, G. et al., Current methods and advances in bone densitometry, Eur. Radiol., 5, 129, 1995.
23. Gasser, J. A., Quantitative assessment of bone mass and geometry by pQCT in rats in vivo and site specificity of changes at different skeletal sites, J. Jpn. Soc. Bone Morphom., 7, 107, 1997.
24. Barck, K. H. et al., Quantification of cortical bone loss and repair for therapeutic evaluation in collagen-induced arthritis, by micro-computed tomography and automated image analysis, Arthritis Rheum., 50, 3377, 2004.
25. Morenko, B. J. et al., In vivo micro computed tomography of subchondral bone in the rat after intra-articular administration of monosodium iodoacetate, Contemp. Top. Lab. Anim. Sci., 43, 39, 2004.
26. Ford, N. L., Thornton, M. M., and Holdsworth, D. W., Fundamental image quality limits for microcomputed tomography in small animals, Med. Phys., 30, 2869, 2003.
27. Beckmann, N. et al., Noninvasive 3D MR microscopy as a tool in pharmacological research: application to a model of rheumatoid arthritis, Magn. Reson. Imaging, 13, 1013, 1995.
28. Beckmann, N. et al., Effects of Sandimmune neoral on collagen-induced arthritis in DA rats: characterization by high resolution three-dimensional magnetic resonance imaging and by histology, J. Magn. Reson., 131, 8, 1998.
29. Dawson, J., Gustard, S., and Beckmann, N., High-resolution three-dimensional magnetic resonance imaging for the investigation of knee joint damage during the time course of antigen-induced arthritis in rabbits, Arthritis Rheum., 42, 119, 1999.
30. Faure, P., Doan, B. T., and Beloeil, J. C., In-vivo high resolution three-dimensional MRI studies of rat joints at 7 T, NMR Biomed., 16, 484, 2003.
31. Jacobson, P. B. et al., A new spin on an old model: in vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat, Arthritis Rheum., 42, 2060, 1999.
32. Harris, R. et al., ABT-963, a highly potent and selective disubstituted pyridazinone COX-2 inhibitor, J. Pharmacol. Exp. Ther., 311, 904, 2004.
33. Badger, A. M. et al., Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogenactivated protein kinase, in rat adjuvant-induced arthritis, Arthritis Rheum., 43, 175, 2000.
34. Badger, A. M. et al., Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis, Arthritis Rheum., 44, 128, 2001.
35. Gaffney, K. et al., Quantification of rheumatoid synovitis by magnetic resonance imaging, Arthritis Rheum., 38, 1610, 1995.
36. Ostergaard, M. et al., Quantification of synovistis by MRI: correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation, Magn. Reson. Imaging, 16, 743, 1998.
37. Ostergaard, M. et al., Quantitative assessment of synovial inflammation by dynamic gadoliniumenhanced MRI. A study of the effect of intraarticular methylprednisolone on the rate of early synovial enhancement, Br. J. Rheumatol., 35, 50, 1996.
38. Jevtic, V. et al., Prognostic value of contrast enhanced Gd-DTPA-MRI for development of bone erosive changes in rheumatoid arthritis, Br. J. Rheumatol., 35 (Suppl. 3), 26, 1996.
39. Gaffney, K. et al., Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging, Ann. Rheum. Dis., 57, 152, 1998.
40. Tofts, P. S. and Kermode, A. G., Measurement of the blood/brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts, Magn. Reson. Med., 17, 357, 1991.
41. Singh, H. N. et al., Synovial fluid levels of tumor necrosis factor-alpha in the inflamed rat knee: modulation by dexamethasone and inhibitors of matrix metalloproteinase and phosphodiesterase, Inflamm. Res., 46 (Suppl. 2), S153, 1997.
42. Yang, Y. et al., Antiinflammatory effect of lipocortin 1 in experimental arthritis, Inflammation, 21, 583, 1997.
43. Taylor, P. C., VEGF and imaging of vessels in rheumatoid arthritis, Arthritis Res., 4 (Suppl. 3), S99, 2002.
44. Koch, A. E., Angiogenesis as a target in rheumatoid arthritis, Ann. Rheum. Dis., 62 (Suppl. 2), ii60, 2003.
45. Polytarchou, C. and Papadimitriou, E., Antioxidants inhibit angiogenesis in vivo through downregulation of nitric oxide synthase expression and activity, Free Radic. Res., 38, 501, 2004.
46. Cutolo, M., Macrophages as effectors of the immunoendocrinologic interactions in autoimmune rheumatic diseases, Ann. NY. Acad. Sci., 876, 32, 1999.
47. Weissleder, R. et al., Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging, Radiology, 175, 489, 1990.
48. Dardzinski, B. J. et al., MR imaging of murine arthritis using ultrasmall superparamagnetic iron oxide particles, Magn. Reson. Imaging, 19, 1209, 2001.
49. Beckmann, N. et al., Macrophage infiltration into the rat knee detected by MRI in a model of antigeninduced arthritis, Magn. Reson. Med., 49, 1047, 2003.
50. Lutz, A. M. et al., Detection of synovial macrophages in an experimental rabbit model of antigeninduced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging, Radiology, 233, 149, 2004.
51. Heinegard, D. and Oldberg, A., Structure and biology of cartilage and bone matrix noncollagenous macromolecules, FASEB J., 3, 2042, 1989.
52. Torchia, D. A., Hasson, M. A., and Hascall, V. C., Investigation of molecular motion of proteoglycans in cartilage by 13C magnetic resonance, J. Biol. Chem., 252, 3617, 1977.
53. Grushko, G., Schneiderman, R., and Maroudas, A., Some biochemical and biophysical parameters for the study of the pathogenesis of osteoarthritis: a comparison between the processes of ageing and degeneration in human hip cartilage, Conn. Tissue Res., 19, 149, 1989.
54. Kempson, G. E. et al., The tensile properties of human femoral condyles related to the content of collagen and glycosaminoglycans, Biochim. Biophys. Acta, 297, 456, 1973.
55. Eckstein, F. et al., Quantitative relationships of normal cartilage volumes of the human knee joint-assessment by magnetic resonance imaging, Anat. Embryol. (Berl.), 197, 383, 1998.
56. Burgkart, R. et al., Magnetic resonance imaging-based assessment of cartilage loss in severe osteoarthritis: accuracy, precision, and diagnostic value, Arthritis Rheum., 44, 2072, 2001.
57. Peterfy, C. G., Applications of MRI for evaluating osteoarthritis, In Advances in Osteoarthritis, Tanaka, S. and Hamanishi, C., Eds., Springer, Tokyo, pp. 74-92, 1999.
58. Tessier, J. J. et al., Characterization of the guinea pig model of osteoarthritis by in vivo three-dimensional magnetic resonance imaging, Osteoarthritis Cartilage, 11, 841, 2003.
59. Calvo, E. et al., High-resolution MRI detects cartilage swelling at the early stages of experimental osteoarthritis, Osteoarthritis Cartilage, 9, 463, 2001.
60. Lohmander, L. S., Articular cartilage and osteoarthritis. The role of molecular markers to monitor breakdown, repair and disease, J. Anat., 184, 477, 1994.
61. Bank, R. A. et al., The increased swelling and instantaneous deformation of osteoarthtitic cartilage is highly correlated with collagen degradation, Arthritis Rheum., 43, 2202, 2000.
62. Fragonas, E. et al., Correlation between biochemical composition and magnetic resonance appearance of articular cartilage, Osteoarthritis Cartilage, 6, 24, 1998.
63. Borthakur, A. et al., Sensitivity of MRI to proteoglycan depletion in cartilage: comparison of sodium and proton MRI, Osteoarthritis Cartilage, 8, 288, 2000.
64. Burstein, D. et al., Diffusion of small solutes in cartilage as measured by nuclear magnetic resonance (NMR) spectroscopy and imaging, J. Orthop. Res., 11, 465, 1993.
65. Lesperance, L. M., Gary, M. L., and Burstein, D., Determination of fixed charge density in cartilage using nuclear magnetic resonance, J. Orthop. Res., 10, 1, 1992.
66. 23Na MRI accurately measures fixed charge density in articular cartilage, Magn. Reson. Med., 47, 284, 2002.
67. 1 rho-relaxation of articular cartilage at 4 T, Magn. Reson. Med., 46, 419, 2001.
68. Duvvuri, U. et al., T(1rho) relaxation can assess longitudinal proteoglycan loss from articular cartilage in vitro, Osteoarthritis Cartilage, 10, 838, 2002.
69. 2− as a measure of cartilage degradation, Magn. Reson. Med., 36, 665, 1996.
70. Bashir, A. et al., Nondestructive imaging of human cartilage glycosaminoglycan concentration depletion in articular cartilage, Magn. Reson. Med., 41, 857, 1999.
71. Donahue, K. M. et al., Studies of Gd-DTPA relaxivity and proton exchange rates in tissue, Magn. Reson. Med., 32, 66, 1994.
72. Kusaka, Y. et al., MR microimaging of articular cartilage and contrast enhancement by manganese ions, Magn. Reson. Med., 24, 137, 1992.
73. Bacic, G. et al., MRI contrast enhanced study of cartilage proteoglycan degradation in rabbit knee, Magn. Reson. Med., 37, 764, 1997.
74. Nissi, M. J. et al., Proteoglycan and collagen sensitive MRI evaluation of normal and degenerated articular cartilage, J. Orthop. Res., 22, 557, 2004.
75. 1 rho MRI in articular cartilage systems, Magn. Reson. Med., 51, 503, 2004.
76. Kim, D. K. et al., Analysis of water-macromolecule proton magnetization transfer in articular cartilage, Magn. Reson. Med., 29, 211, 1993.
77. Vahlensieck, M. et al., Magnetization transfer contrast (MTC) and MTC-substraction: enhancement of cartilage lesions and intra-cartilaginous degeneration in vitro, Skeletal Radiol., 23, 535, 1994.
78. Gray, M. L. et al., Magnetization transfer in cartilage and its constituent macromolecules, Magn. Reson. Med., 34, 319, 1995.
79. Armstrong, S. J. et al., Moderate exercise exacerbates the osteoarthritic lesions produced in cartilage by meniscectomy: a morphological study, Osteoarthritis Cartilage, 1, 89, 1993.
80. Schmiedl, U. et al., Albumin labeled with Gd-DTPA as an intravascular, blood pool enhancing agent for MR imaging: biodistribution of gadolinium, Radiology, 162, 205, 1987.
81. van Dijke, C. F. et al., MR imaging of the arthritic rabbit knee joint using albumin-(Gd-DTPA)30 with correlation to histopathology, Magn. Reson. Imaging, 17, 237, 1999.
82. Jiang, Y. et al., MRI of antigen-induced arthritis in rabbits: improved contrast and disease characterization with the blood pool agent MS-325, Acad. Radiol., 9 (Suppl. 2), S480, 2002.
83. Grunder, W. et al., Improved nuclear magnetic resonance microscopic visualization of joint cartilage using liposome entrapped contrast agents, Invest. Radiol., 33, 193, 1998.
84. Sipkins, D. A. et al., ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging, J. Neuroimmunol., 104, 1, 2000.
85. Mulder, W. J. et al., A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets, Bioconjug. Chem., 15, 799, 2004.
86. Kang, H. W. et al., Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture, Bioconjug. Chem., 13, 122, 2002.
87. Hohe, J. et al., A technique for 3D in vivo quantification or proton density and magnetization transfer coefficients of knee joint cartilage, Osteoarthritis Cartilage, 8, 426, 2000.
88. Gasson, J. et al., Magnetic resonance imaging of rheumatoid arthritis in metacarpophalangeal joints, Skeletal Radiol., 29, 324, 2000.
89. Burstein, D. et al., Protocol issues for delayed Gd(DTPA)(2 2)-enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage, Magn. Reson. Med., 45, 36, 2001.
90. Gray, M. L. et al., Toward imaging biomarkers for osteoarthritis, Clin. Orthop., 427, S175, 2004.
91. Williams, A. et al., Glycosaminoglycan distribution in cartilage as determined by delayed gadoliniumenhanced MRI of cartilage (dGEMRIC): potential clinical applications, Am. J. Roentgenol., 182, 167, 2004.
92. Tiderius, C. J. et al., dGEMRIC (delayed gadolinium-enhanced MRI of cartilage) indicates adaptive capacity of human knee cartilage, Magn. Reson. Med., 51, 286, 2004.
93. Gandy, S. J. et al., No loss of cartilage volume over three years in patients with knee osteoarthritis as assessed by magnetic resonance imaging, Osteoarthritis Cartilage, 10, 929, 2002.
94. 1 values by SNAPSHOT-FLASH NMR imaging, J. Magn. Reson., 96, 608, 1992.
95. Rudin, M. and Sauter, A., Measurement of reaction rates in vivo using magnetization transfer techniques, In Basic Principles and Progress, Vol. 27, Diehl, P., Ed., Springer, Heidelberg, 257, 1992.
96. Venn, M. and Maroudas, A., Chemical composition and swelling of normal and osteoarthritic femoral head cartilage. I. Chemical composition, Ann. Rheum. Dis., 36, 121, 1977.